Low sodium urine concentration is associated with poor survival in patients with HRS

Background and Objectives: Terlipressin plus albumin therapy for hepatorenal syndrome (HRS) has become an accepted and effective regimen. However, only 50% to 60% of the patients respond to the treatment. Since this therapy is associated with high cost and risk for adverse effects, more accurate predictors for response to therapy are warranted. Therefore we checked i) the response to therapy on the basis of clinical or etiological parameters before treatment ii) the short- and long-term survival and iii) the correlation between treatment response and overall mortality. Methods: A retrospective evaluation of 21 p…